V316A (p.Val316Ala) variant of GLA (Alpha-galactosidase A)

V316A (p.Val316Ala) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype; Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes published literature and structural context.

V316A (p.Val316Ala) variant details